CAMBRIDGE, Mass., March 22, 2016 -- Metabolix, Inc. (NASDAQ:MBLX), an advanced biomaterials company focused on sustainable solutions for the plastics industry, announced today that it will be releasing its fourth quarter and full year 2015 financial results after the market close on Tuesday, March 29, 2016. The full text of the earnings release also will be available on the Company’s website at www.metabolix.com.
The Company will host a conference call on the same day at 4:30 p.m. (ET), during which senior management will provide an update on the business and answer questions from the investment community.
While shareholders participate in the call in listen-only mode, Metabolix invites shareholders to submit questions for consideration to [email protected] with the subject line: “Questions for Fourth Quarter Call.” Questions submitted in advance of the call will be reviewed and certain of them may be addressed in management's prepared remarks or in the Q&A portion of the call.
A live webcast of the call with slides can be accessed through the “Investors” section of the Company’s website at www.metabolix.com. To participate in the call, dial toll-free (877) 709-8150 or (201) 689-8354 (international). Interested parties unable to participate in the live call may access an archived version of the webcast on the Company’s website. To listen to a telephonic replay of the conference call, dial toll-free (877) 660-6853 or (201) 612-7415 (international) and enter passcode 13630506. The replay will be available beginning at 7:30 p.m. (ET) on Tuesday, March 29, 2016 and will last through 11:59 p.m. (ET) on Monday, April 11, 2016. In addition, the webcast will be archived on the Company’s website in the investor relations section.
About Metabolix
Metabolix, Inc. is an innovation-driven specialty materials company focused on delivering high- performance biopolymer solutions to customers in the plastics industry. Metabolix’s Mirel® biopolymers, which are derived from renewable resources, are a family of biobased performance additives and specialty resins based on PHA (polyhydroxyalkanoates). Metabolix's proprietary biotechnology platform enables the creation of specialty biopolymers for use in a broad range of applications such as construction and packaging materials, as well as industrial, consumer and personal care products.
For more information, please visit www.metabolix.com. (MBLX-E)
Metabolix Contact: Lynne H. Brum, (617) 682-4693, [email protected]


JAPEX Shares Drop as Middle East Tensions Drive LNG Costs and Production Risks
Greg Abel Sells Berkshire Hathaway Stocks Managed by Former Investment Manager Todd Combs
Australia Extends Fuel Sulphur Relaxation Amid Iran War Supply Disruptions
Huawei Expands Vietnam Presence Through Strategic Partnership with SHB Bank
Elon Musk Faces French Probe Over X and Grok Amid Rising U.S.-EU Tensions
Indonesia and Toyota Explore $300M Bioethanol Investment to Boost Renewable Energy Goals
China Food Delivery Stocks Dip as Regulators Crack Down on “Ghost Deliveries”
Japan to Subsidize Sony's Image Sensor Plant in Kumamoto with $380 Million
Anthropic CEO Meets Trump Officials to Discuss Powerful New AI Model Mythos
Eli Lilly in Talks to Acquire Kelonia Therapeutics for Over $2 Billion
Tesla Q1 Earnings Preview: Robotaxi Delays and SpaceX Merger Speculation Grow
Ethiopian Airlines Expands Fleet with New Boeing 787 Dreamliner Order to Boost Global Routes
Indian Refiners Use Yuan via ICICI Bank to Pay for Iranian Oil Under U.S. Sanctions Waiver
AEVEX Raises $320 Million in IPO Amid Surging Defense Sector Demand
Amazon Expands AI Bet with Up to $25 Billion Investment in Anthropic
Apple Wins ITC Ruling, Keeping Blood-Oxygen Feature on Apple Watch
Apple Stock Dips as Tim Cook Steps Down, John Ternus Named Next CEO 



